Heads up for HT patients,
Merck's patent on the osteoperosis drug Fosamax will expire tomorrow, and the generics are ready to roll out. Those who are on hormone therapy may pay less very soon. With my insurance I pay $30.00 for Fosamax and $10.00 for generics. So I will save $20.00 per month. Those without the insurance will save much more. Story is available on most business web pages.
Tony
Age 45 (44 when Dx)
Pre-op PSA was 19.8
Surgery on Feb 16, 2007
Post-Op Pathology: Gleason 4+3=7, positive margins, Stage pT3b (Stage III)
HT began in May, '07 with Lupron and Casodex 50mg
IMRT radiation for 38 Treatments ending August 3, '07
Current PSA (1/08): <0.1
I will continue HT until May '09.
Visit my Journey at:
STAY POSITIVE!